Bruce J. Seeley has been named executive vice president, commercial at Seattle Genetics. Mr. Seeley brings more than 18 years of experience in oncology drug marketing and sales to the company, most recently from Genentech BioOncology. The company also promoted Kirk D. Schumacher to vice president, legal affairs and compliance, and general counsel. “Bruce will lead our efforts to build Seattle Genetics’ marketing and sales functions as we position the company for commercial operations, includi...